The aim of this study is to compare the vitamin D level among vaccinated and nonvaccinated pregnant women with COVID-19.

Total 120 pregnant women had coronavirus disease were presented. Informed written consent was taken for details, demographics age, gestational age, parity and body mass index. Patients were categorized into 2-groups. Group I had 60 vaccinated patients and in group II 60 non-vaccinated pregnant women. Blood sample of all the patients were taken for the level of serum 25-hydroxy vitaminD3 [25 (OH) D3]. Vitamin D deficiency was calculated and compared among both groups. Sufficient serum vitamin D level was considered >30ng/ml. SPSS 23.0version was used to analyze complete data.

In group I 51(85%) patients had vitamin D deficiency and in group II 54 (90%) had deficiency of vitamin D. Among 51 deficient women of group I, number of severe deficiency (<10ng/ml) women were 8 (13.3%), deficiency (10-20ng/ml) were 13 (21.7%) and not-sufficient (20-30ng/ml) were 30 (50%). In group II prevalence of severity (<10ng/ml) patients were 10 (16.7%), deficient cases (10- 20ng/ml) were 15 (25%) and notsufficient cases (20-30ng/ml) were 29 (48.3%). Deficient vitamin D serum levels were 15.01±1.22 in group I and 14.34±4.12 in group II.

In this study we concluded that prevalence of vitamin D deficiency was highly among pregnant women and most probably in nonvaccinated pregnant patients but did not find any significantly difference among both groups.